Systolic blood pressure reduction with stability as a new therapeutic goal in patients with intracerebral hemorrhage: results of the pooled analysis of ATACH 2 and INTERACT 2 trials
Background: The American Heart Association/American Stroke Association recommends achieving systolic blood pressure (SBP) therapeutic targets within 60 min of initiating treatment for intracerebral hemorrhage (ICH), emphasizing avoidance of “overshoot” correction and SBP fluctuations. We evaluated t...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
20 May 2025
|
| In: |
Neurocritical care
|
| ISSN: | 1556-0961 |
| DOI: | 10.1007/s12028-025-02277-2 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s12028-025-02277-2 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s12028-025-02277-2 
|
| Verfasserangaben: | Adnan I. Qureshi, William Baskett, Renee H. Martin, Pashmeen Lakhani, Ibrahim A. Bhatti, Hijrah El Sabae, Fawaz Al-Mufti, Joao A. Gomes, Ali Seifi, Alejandro A. Rabinstein, Jose I. Suarez, Thorsten Steiner, Chi-Ren Shyu and Craig S. Anderson |
MARC
| LEADER | 00000naa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1940617286 | ||
| 003 | DE-627 | ||
| 005 | 20251106183701.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251106s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12028-025-02277-2 |2 doi | |
| 035 | |a (DE-627)1940617286 | ||
| 035 | |a (DE-599)KXP1940617286 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Qureshi, Adnan |e VerfasserIn |0 (DE-588)1149303735 |0 (DE-627)1009622307 |0 (DE-576)496724185 |4 aut | |
| 245 | 1 | 0 | |a Systolic blood pressure reduction with stability as a new therapeutic goal in patients with intracerebral hemorrhage |b results of the pooled analysis of ATACH 2 and INTERACT 2 trials |c Adnan I. Qureshi, William Baskett, Renee H. Martin, Pashmeen Lakhani, Ibrahim A. Bhatti, Hijrah El Sabae, Fawaz Al-Mufti, Joao A. Gomes, Ali Seifi, Alejandro A. Rabinstein, Jose I. Suarez, Thorsten Steiner, Chi-Ren Shyu and Craig S. Anderson |
| 264 | 1 | |c 20 May 2025 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.11.2025 | ||
| 520 | |a Background: The American Heart Association/American Stroke Association recommends achieving systolic blood pressure (SBP) therapeutic targets within 60 min of initiating treatment for intracerebral hemorrhage (ICH), emphasizing avoidance of “overshoot” correction and SBP fluctuations. We evaluated the prognostic value of “SBP reduction with stability,” a novel end point combining controlled blood pressure reduction and maintenance, using data from two large multinational clinical trials. Methods: We analyzed patients with ICH from Antihypertensive Treatment of Acute Cerebral Hemorrhage 2 and Intensive BP Reduction in Acute Cerebral Hemorrhage Trial 2 trials presenting with initial SBP 150–220 mm Hg. SBP reduction with stability was defined as achieving and maintaining SBP between 130 and 150 mm Hg within the first hour after randomization based on consecutive recordings. Outcomes included functional independence (modified Rankin scale 0–2) at 90 days and neurological deterioration within 24 h, adjusted for potential confounders. Results: Among 3,694 patients with ICH (2,781 patients from Intensive BP Reduction in Acute Cerebral Hemorrhage Trial 2 and 913 patients from Antihypertensive Treatment of Acute Cerebral Hemorrhage 2), 1,061 patients (28.7%) achieved SBP reduction with stability within 1 h. Patients had mean age 63.3 ± 12.9 years, baseline SBP 177.14 ± 18.28 mm Hg, and median hematoma volume of 10.78 mL (interquartile range 5.5–19.16). Achieving SBP reduction with stability significantly improved functional independence odds (odds ratio 1.38, 95% confidence interval 1.16–1.64) and reduced neurological deterioration odds (odds ratio 0.68, 95% confidence interval 0.53–0.88) after adjusting for initial SBP, Glasgow Coma Scale, age, sex, stroke history, hypertension, diabetes mellitus, study, ICH location, hematoma volume, and intraventricular hemorrhage presence. Conclusions: Only 30% of patients with mild‑to‑moderate ICH achieved SBP reduction with stability within the first hour. This achievement was associated with improved functional outcomes and reduced early neurological deterioration. These findings suggest that SBP reduction with stability represents a valuable therapeutic target for future clinical trials in ICH management. | ||
| 650 | 4 | |a Clinical trial | |
| 650 | 4 | |a Functional outcome | |
| 650 | 4 | |a ICH | |
| 650 | 4 | |a Stability | |
| 650 | 4 | |a Systolic blood pressure | |
| 700 | 1 | |a Baskett, William |e VerfasserIn |4 aut | |
| 700 | 1 | |a Martin, Renee H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lakhani, Pashmeen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bhatti, Ibrahim A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a El Sabae, Hijrah |e VerfasserIn |4 aut | |
| 700 | 1 | |a Al-Mufti, Fawaz |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gomes, Joao A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Seifi, Ali |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rabinstein, Alejandro A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Suarez, Jose I. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Steiner, Thorsten |d 1961- |e VerfasserIn |0 (DE-588)118107623 |0 (DE-627)079247407 |0 (DE-576)291718779 |4 aut | |
| 700 | 1 | |a Shyu, Chi-Ren |e VerfasserIn |4 aut | |
| 700 | 1 | |a Anderson, Craig S. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurocritical care |d New York, NY : Springer, 2004 |g (2025), Early Access, 9 Seiten |h Online-Ressource |w (DE-627)478509855 |w (DE-600)2176033-0 |w (DE-576)306831910 |x 1556-0961 |7 nnas |a Systolic blood pressure reduction with stability as a new therapeutic goal in patients with intracerebral hemorrhage results of the pooled analysis of ATACH 2 and INTERACT 2 trials |
| 773 | 1 | 8 | |g year:2025 |a Systolic blood pressure reduction with stability as a new therapeutic goal in patients with intracerebral hemorrhage results of the pooled analysis of ATACH 2 and INTERACT 2 trials |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s12028-025-02277-2 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s12028-025-02277-2 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20251106 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 118107623 |a Steiner, Thorsten |m 118107623:Steiner, Thorsten |d 910000 |d 911100 |d 50000 |e 910000PS118107623 |e 911100PS118107623 |e 50000PS118107623 |k 0/910000/ |k 1/910000/911100/ |k 0/50000/ |p 12 | ||
| 999 | |a KXP-PPN1940617286 |e 4797771992 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Systolic blood pressure reduction with stability as a new therapeutic goal in patients with intracerebral hemorrhage","subtitle":"results of the pooled analysis of ATACH 2 and INTERACT 2 trials","title_sort":"Systolic blood pressure reduction with stability as a new therapeutic goal in patients with intracerebral hemorrhage"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1007/s12028-025-02277-2"],"eki":["1940617286"]},"relHost":[{"recId":"478509855","name":{"displayForm":["Neurocritical Care Society"]},"origin":[{"publisher":"Springer ; Humana Press","dateIssuedDisp":"2004-","dateIssuedKey":"2004","publisherPlace":"New York, NY ; Totowa, NJ"}],"title":[{"title_sort":"Neurocritical care","title":"Neurocritical care"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2176033-0"],"issn":["1556-0961"],"eki":["478509855"]},"note":["Gesehen am 11.09.14"],"pubHistory":["1.2004 -"],"language":["eng"],"part":{"text":"(2025), Early Access, 9 Seiten","year":"2025"},"disp":"Systolic blood pressure reduction with stability as a new therapeutic goal in patients with intracerebral hemorrhage results of the pooled analysis of ATACH 2 and INTERACT 2 trialsNeurocritical care","type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedDisp":"20 May 2025","dateIssuedKey":"2025"}],"name":{"displayForm":["Adnan I. Qureshi, William Baskett, Renee H. Martin, Pashmeen Lakhani, Ibrahim A. Bhatti, Hijrah El Sabae, Fawaz Al-Mufti, Joao A. Gomes, Ali Seifi, Alejandro A. Rabinstein, Jose I. Suarez, Thorsten Steiner, Chi-Ren Shyu and Craig S. Anderson"]},"language":["eng"],"recId":"1940617286","person":[{"display":"Qureshi, Adnan","given":"Adnan","role":"aut","family":"Qureshi"},{"display":"Baskett, William","given":"William","role":"aut","family":"Baskett"},{"family":"Martin","role":"aut","display":"Martin, Renee H.","given":"Renee H."},{"role":"aut","family":"Lakhani","given":"Pashmeen","display":"Lakhani, Pashmeen"},{"role":"aut","family":"Bhatti","display":"Bhatti, Ibrahim A.","given":"Ibrahim A."},{"family":"El Sabae","role":"aut","display":"El Sabae, Hijrah","given":"Hijrah"},{"given":"Fawaz","display":"Al-Mufti, Fawaz","family":"Al-Mufti","role":"aut"},{"role":"aut","family":"Gomes","display":"Gomes, Joao A.","given":"Joao A."},{"display":"Seifi, Ali","given":"Ali","role":"aut","family":"Seifi"},{"role":"aut","family":"Rabinstein","given":"Alejandro A.","display":"Rabinstein, Alejandro A."},{"given":"Jose I.","display":"Suarez, Jose I.","role":"aut","family":"Suarez"},{"given":"Thorsten","display":"Steiner, Thorsten","role":"aut","family":"Steiner"},{"family":"Shyu","role":"aut","display":"Shyu, Chi-Ren","given":"Chi-Ren"},{"given":"Craig S.","display":"Anderson, Craig S.","role":"aut","family":"Anderson"}],"note":["Gesehen am 06.11.2025"]} | ||
| SRT | |a QURESHIADNSYSTOLICBL2020 | ||